Concepedia

Michael A. Bowen

MA

65

Publications

3.6K

Citations

33

H-Index

1993

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Washington

AstraZeneca (United States)

University College London

Michael A. Bowen is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1993–2022

65

Publications

65

Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.

Michael A. Bowen, Dhavalkumar D. Patel, X Li et al. · The Journal of Experimental Medicine · 1995 · 383 citations · Full text

, , +19

CD5 Negatively Regulates the T-Cell Antigen Receptor Signal Transduction Pathway: Involvement of SH2-Containing Phosphotyrosine Phosphatase SHP-1

Juan J. Pérez‐Villar, Gena S. Whitney, Michael A. Bowen et al. · Molecular and Cellular Biology · 1999 · 204 citations

Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer

Feng Chen, Kai Ma, Brian Madajewski et al. · Nature Communications · 2018 · 179 citations · Full text

Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.

Dhavalkumar D. Patel, S. Wee, Leona P. Whichard et al. · The Journal of Experimental Medicine · 1995 · 151 citations · Full text

, , +16

Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry

Michael Pete VanBrunt, Kurt Shanebeck, Zachary Caldwell et al. · Bioconjugate Chemistry · 2015 · 137 citations

, , +15

Rows per page

1–5 of 65